Astrazeneca (AZN) Interest & Investment Income (2009 - 2026)
Astrazeneca's Interest & Investment Income was $67 million in Q3 2026, down 21.2% from $85 million a year earlier and down 16.3% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Interest & Investment Income (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's Interest & Investment Income was $355 million through Sep 30, 2026, up 17.9% year-over-year; for FY2025, it was $360 million, down 21.4% from FY2024.
- Interest & Investment Income shows a five-year compound annual growth rate of 32.8% (FY2020 to FY2025).
- In earlier years, Interest & Investment Income was $458 million in FY2024 (+33.1%), $344 million in FY2023 (+262.1%), $95 million in FY2022 (+120.9%) and $43 million in FY2021 (-50.6%).
- The Q3 2026 figure marks the lowest quarterly Interest & Investment Income since Q4 2024.
- Compared with a year earlier, Interest & Investment Income was higher in two of the last eight quarters, with an average decline of 7.0%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2023 (growth of 573.3%); the worst was Q4 2021 (a decline of 85.7%).
- Per Business Quant data, AZN's Interest & Investment Income in the three quarters before Q3 2026 was $80 million (Q2 2026), $73 million (Q1 2026) and $135 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 118.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 67.00 Mn |
| Jun 30, 2026 | 80.00 Mn |
| Mar 31, 2026 | 73.00 Mn |
| Dec 31, 2025 | 135.00 Mn |
| Sep 30, 2025 | 85.00 Mn |
| Jun 30, 2025 | 68.00 Mn |
| Mar 31, 2025 | 84.00 Mn |
| Dec 31, 2024 | 64.00 Mn |
| Sep 30, 2024 | 183.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 111.00 Mn |
| Dec 31, 2023 | 108.00 Mn |
| Sep 30, 2023 | 101.00 Mn |
| Jun 30, 2023 | 64.00 Mn |
| Mar 31, 2023 | 78.00 Mn |
| Dec 31, 2022 | 45.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 18.00 Mn |
| Mar 31, 2022 | 17.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
API Access
Astrazeneca Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();